Lessons from Rare Renal and Adrenal Diseases
نویسندگان
چکیده
منابع مشابه
Pathophysiological lessons from rare associations of autoimmune diseases
Membranous nephropathy (MN) is a non-proliferative glomerular disease characterized by accumulation of immune deposits on the outer aspect of the glomerular basement membrane (GBM) leading to complement activation and proteinuria. Eighty per cent of cases are referred to as ‘idiopathic MN’ (iMN), while ~20% are classified as ‘secondary’ because they occur in patients presenting with associated ...
متن کاملMonitoring of Adrenal Functions Amid the COVID-19 Pandemic: Lessons From Pediatric Leukemia
Introduction: Glucocorticoids are considered the cornerstone of the induction phase in all treatment protocols of acute lymphoblastic leukemia (ALL). Among the adverse effects of high-dose glucocorticoid treatment, adrenal insufficiency is secondary to suppression of the hypothalamic-pituitary-adrenal (HPA) axis. This drawback of exogenous steroid therapy gains a contemporary particular relevan...
متن کاملAdrenal pathophysiology: lessons from the Carney complex.
The Carney complex (CNC) is a dominantly inherited syndrome responsible mainly for spotty skin pigmentation (lentiginosis), endocrine overactivity, and cardiac myxomas. Adrenocorticotropic hormone independent Cushing's syndrome due to primary pigmented nodular adrenocortical disease (PPNAD) is a main characteristic of CNC. PPNAD is a very rare cause of Cushing's syndrome due to a primary bilate...
متن کاملVesicle Pools: Lessons from Adrenal Chromaffin Cells
The adrenal chromaffin cell serves as a model system to study fast Ca2+-dependent exocytosis. Membrane capacitance measurements in combination with Ca2+ uncaging offers a temporal resolution in the millisecond range and reveals that catecholamine release occurs in three distinct phases. Release of a readily releasable (RRP) and a slowly releasable (SRP) pool are followed by sustained release, d...
متن کاملA journey of hope: lessons learned from studies on rare diseases and orphan drugs.
Rare diseases are frequently life-threatening or chronically debilitating and the impact on the quality of life of affected patients and their family members is thus significant. However, drug development for these conditions has been limited by a lack of understanding of the underlying mechanisms of disease and the relative unavailability of subjects for clinical trials, as well as the prohibi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Journal of the American Society of Nephrology
سال: 2009
ISSN: 1555-9041,1555-905X
DOI: 10.2215/cjn.01930309